Myriad Genetics Inc. (MYGN: Quote) Tuesday reported third-quarter profit of $37.9 million or $0.46 per share, up from $29.6 million or $0.34 per share in same period last year.

On average, 17 analysts polled by Thomson Reuters expected the company to earn $0.40 per share for the quarter. Analysts' estimates typically exclude special items.

Revenues improved to $156.47 million from $129.78 million last year. Analysts expected revenues of $148.25 million.

Looking ahead, the company has raised its full-year 2013 earnings outlook to a range of $1.65 to $1.67 per share from the previous guidance of $1.55 to $1.58 per share.

Revenues are currently projected in a range of $595 million to $600 million, up from $575 million to $585 million, issued previously. Analysts currently expect the company to report full-year earnings of $1.58 per share on revenues of $583.50 million.

Click here to receive FREE breaking news email alerts for Myriad Genetics Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Follow this link:
Myriad Genetics Q3 Profit Up 28%, Lifts FY13 Outlook - Quick Facts

Comments are closed.